Exosome Research Market Expected To Reach $661 million by 2026
The growth of this market is driven by factors such as the rising funding for life sciences research, the high global prevalence of cancer, and the increasing interest in exosome-based procedures.
According to the new market research report "Exosome Research Market by Product and services (Kits, Reagents, Instrument), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell, Dendritic cell-derived), End User - Global Forecast to 2026", published by MarketsandMarkets™, the global market is projected to reach USD 661 million by 2026 from USD 144 million in 2021, at a CAGR of 35.6% during the forecast period.
Browse in-depth TOC on
"Exosome Research Market"
229 – Tables
32 – Figures
191 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=224782498
The growth of this market is driven by factors such as the rising funding for life sciences research, the high global prevalence of cancer, and the increasing interest in exosome-based procedures. However, the dearth of skilled professionals is a major factor that is expected to restrain the growth of this market to a certain extent in the coming years.
Kits & Reagents segment accounted for the largest share of exosome research market
Based on product and service, the exosome research product market is segmented into kits & reagents, instruments, and services. The kits & reagents segment is further divided into antibodies, isolation, purification, quantitation kits & reagents, and other kits & reagents.
Most pharmaceutical, biopharmaceutical, and medical device companies invest heavily in developing novel drugs and devices. The pharmaceutical industry is R&D-intensive. Pharmaceutical companies invest in R&D to deliver high-quality and innovative products to the market.
The exosomes secreted by tumor cells promote tumor progression, survival, invasion, and angiogenesis. Hence, the analysis of exosomes isolated from the blood or other body fluids of cancer patients could provide insights into cancer cell biology and serve as noninvasive predictive biomarkers for early detection, progression, and metastasis.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=224782498
Biomarkers segment accounted for the largest share of the exosome research market
Based on application, the exosome research product market is segmented into biomarkers, vaccine development, tissue regeneration, and other applications. Exosomes can be isolated from easily attainable biofluids, including blood, urine, and saliva; this has supported their use as biomarkers in disease management. Exosomes are also being used in developing vaccines against the COVID-19 virus, which accounts for the high growth rate of the vaccine development segment.
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian